{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T02:33:29Z","timestamp":1785465209683,"version":"3.56.0"},"reference-count":30,"publisher":"The Endocrine Society","issue":"11","funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1135843"],"award-info":[{"award-number":["1135843"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Grollo-Ruzzene Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>Whether serum androgen levels can identify women with \u201candrogen insufficiency\u201d or \u201candrogen excess\u201d is unresolved; thus, what constitutes \u201cnormal\u201d remains uncertain. We sought to determine whether androgens, including 11-oxygenated C19 steroids, vary with age, menstrual cycle, or body mass index (BMI), during the reproductive years.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design and Setting<\/jats:title><jats:p>Cross-sectional study recruited from eastern Australian states.<\/jats:p><\/jats:sec><jats:sec><jats:title>Participants<\/jats:title><jats:p>A total of 588 women, aged 18 to 39 years, who were not pregnant, lactating, or using systemic hormone therapy, with regular menstrual cycles and no previous diagnosis of polycystic ovarian syndrome.<\/jats:p><\/jats:sec><jats:sec><jats:title>Main Outcome Measures<\/jats:title><jats:p>Sex steroids measured using liquid chromatography-tandem mass spectrometry.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Testosterone and androstenedione concentrations were significantly higher during the menstrual cycle mid- and luteal phases than in the early follicular phase, with median values across the cycle of 0.34 nmol\/L (range, 0.04 to 1.01) and 1.97 nmol\/L (range, 0.53 to 7.89), respectively. No cyclical variations were found in dehydroepiandrosterone (DHEA; 4.91 nmol\/L; range, 0.08 to 23.51), 11-ketoandrostenedione (11KA; 7.99 nmol\/L; range, 0.07 to 31.67), or 11-ketotestosterone (11KT; 1.27 nmol\/L; range, 0.03 to 7.61). Overweight women had lower median testosterone (P &lt; 0.05), DHEA (P &lt; 0.05), and 11KA (P &lt; 0.01) levels than normal-weight women. All C19 steroids were significantly lower (P &lt; 0.01) in those aged 35 to 39 years than in those aged 18 to 25 years. The median 11KA\/androstenedione (4.3:1) and 11KT\/testosterone (3.9:1) ratios did not change with age, after adjustment for BMI and cycle stage.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>We have demonstrated that 11KA and 11KT are stable across the menstrual cycle and make major quantitative contributions to the circulating androgen pool. All C19 androgens declined with age before menopause; hence, age-specific reference ranges are required for the interpretation of androgen levels in premenopausal women.<\/jats:p><\/jats:sec>","DOI":"10.1210\/jc.2019-01357","type":"journal-article","created":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T13:04:50Z","timestamp":1565183090000},"page":"5382-5392","source":"Crossref","is-referenced-by-count":116,"title":["Androgens During the Reproductive Years: What Is Normal for Women?"],"prefix":"10.1210","volume":"104","author":[{"given":"Marina A","family":"Skiba","sequence":"first","affiliation":[{"name":"Women\u2019s Health Research Program, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin J","family":"Bell","sequence":"additional","affiliation":[{"name":"Women\u2019s Health Research Program, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakibul M","family":"Islam","sequence":"additional","affiliation":[{"name":"Women\u2019s Health Research Program, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J","family":"Handelsman","sequence":"additional","affiliation":[{"name":"ANZAC Research Institute, University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reena","family":"Desai","sequence":"additional","affiliation":[{"name":"ANZAC Research Institute, University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2955-0415","authenticated-orcid":false,"given":"Susan R","family":"Davis","sequence":"additional","affiliation":[{"name":"Women\u2019s Health Research Program, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2019,8,7]]},"reference":[{"key":"2019100118015788500_bib1","article-title":"Androgens and ovarian function: translation from basic discovery research to clinical impact [published online ahead of print 1 May 2019]","author":"Walters","journal-title":"J Endocrinol"},{"issue":"12","key":"2019100118015788500_bib2","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/S2213-8587(15)00284-3","article-title":"Testosterone in women\u2014the clinical significance","volume":"3","author":"Davis","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7","key":"2019100118015788500_bib3","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1373\/clinchem.2011.181735","article-title":"Accuracy of first and second generation testosterone assays and improvement through sample extraction","volume":"58","author":"Groenestege","year":"2012","journal-title":"Clin Chem"},{"issue":"2","key":"2019100118015788500_bib4","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1210\/jc.2006-1864","article-title":"Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement","volume":"92","author":"Rosner","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2019100118015788500_bib5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/cen.13389","article-title":"Association between biochemical hyperandrogenism parameters and Ferriman-Gallwey score in patients with polycystic ovary syndrome: a systematic review and meta-regression analysis","volume":"87","author":"Amiri","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2019100118015788500_bib6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1001\/jama.294.1.91","article-title":"Circulating androgen levels and self-reported sexual function in women","volume":"294","author":"Davis","year":"2005","journal-title":"JAMA"},{"issue":"2","key":"2019100118015788500_bib7","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/jsm.12774","article-title":"Is there a correlation between androgens and sexual desire in women","volume":"12","author":"Wahlin-Jacobsen","year":"2015","journal-title":"J Sex Med"},{"key":"2019100118015788500_bib8","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jsbmb.2019.04.005","article-title":"Circulating 11-oxygenated androgens across species","volume":"190","author":"Rege","year":"2019","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"7","key":"2019100118015788500_bib9","doi-asserted-by":"crossref","first-page":"e0159867","DOI":"10.1371\/journal.pone.0159867","article-title":"11-Ketotestosterone and 11-ketodihydrotestosterone in castration resistant prostate cancer: potent androgens which can no longer be ignored","volume":"11","author":"Pretorius","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"2019100118015788500_bib10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/1753-6405.12868","article-title":"Challenges in recruitment to an epidemiological study of young Australian women: the Grollo-Ruzzene Foundation Young Women\u2019s Health Study","volume":"43","author":"Skiba","year":"2019","journal-title":"Aust N Z J Public Health"},{"issue":"4","key":"2019100118015788500_bib11","first-page":"1312","article-title":"The use of a sensitive equilibrium dialysis method for the measurement of free testosterone levels in healthy, cycling women and in human immunodeficiency virus-infected women","volume":"83","author":"Sinha-Hikim","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"1-2","key":"2019100118015788500_bib12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.steroids.2010.10.010","article-title":"Reexamination of testosterone, dihydrotestosterone, estradiol and estrone levels across the menstrual cycle and in postmenopausal women measured by liquid chromatography-tandem mass spectrometry","volume":"76","author":"Rothman","year":"2011","journal-title":"Steroids"},{"key":"2019100118015788500_bib13","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.mce.2016.08.014","article-title":"A new dawn for androgens: novel lessons from 11-oxygenated C19 steroids","volume":"441","author":"Pretorius","year":"2017","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"2019100118015788500_bib14","first-page":"95","article-title":"Extragonadal synthesis of sex steroids: intracrinology","volume":"64","author":"Labrie","year":"2003","journal-title":"Ann Endocrinol (Paris)"},{"issue":"12","key":"2019100118015788500_bib15","first-page":"4589","article-title":"11-Ketotestosterone is the dominant circulating bioactive androgen during normal and premature adrenarche","volume":"103","author":"Rege","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2019100118015788500_bib16","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1210\/jc.2015-1023","article-title":"Profiles of 21-carbon steroids in 21-hydroxylase deficiency","volume":"100","author":"Turcu","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2019100118015788500_bib17","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1210\/jc.2016-3285","article-title":"11-Oxygenated C19 steroids are the predominant androgens in polycystic ovary syndrome","volume":"102","author":"O\u2019Reilly","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2019100118015788500_bib18","first-page":"1429","article-title":"Twenty-four-hour mean plasma testosterone concentration declines with age in normal premenopausal women","volume":"80","author":"Zumoff","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2019100118015788500_bib19","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1210\/jc.2005-0212","article-title":"Androgen levels in adult females: changes with age, menopause, and oophorectomy","volume":"90","author":"Davison","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2019100118015788500_bib20","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1373\/clinchem.2010.158600","article-title":"Measured dehydroepiandrosterone sulfate positively influences testosterone measurement in unextracted female serum: comparison of 2 immunoassays with testosterone measured by LC-MS","volume":"57","author":"Benton","year":"2011","journal-title":"Clin Chem"},{"issue":"7","key":"2019100118015788500_bib21","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1210\/jc.2018-02527","article-title":"11-Oxygenated C19 steroids do not decline with age in women","volume":"104","author":"Nanba","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2019100118015788500_bib22","first-page":"1105","article-title":"Body fat accumulation is possibly responsible for lower dehydroepiandrosterone circulating levels in premenopausal obese women","volume":"20","author":"De Pergola","year":"1996","journal-title":"Int J Obes Relat Metab Disord"},{"key":"2019100118015788500_bib23","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.steroids.2018.08.006","article-title":"Increased body fat mass and androgen metabolism\u2014a twin study in healthy young women","volume":"140","author":"Vihma","year":"2018","journal-title":"Steroids"},{"issue":"2","key":"2019100118015788500_bib24","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.fertnstert.2004.07.956","article-title":"Association of body mass index, age, and cigarette smoking with serum testosterone levels in cycling women undergoing in vitro fertilization","volume":"83","author":"Barbieri","year":"2005","journal-title":"Fertil Steril"},{"issue":"3","key":"2019100118015788500_bib25","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/aje\/153.3.256","article-title":"Testosterone concentrations in women aged 25-50 years: associations with lifestyle, body composition, and ovarian status","volume":"153","author":"Sowers","year":"2001","journal-title":"Am J Epidemiol"},{"issue":"10","key":"2019100118015788500_bib26","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1507\/endocrj.EJ18-0212","article-title":"11-Oxygenated C19 steroids as circulating androgens in women with polycystic ovary syndrome","volume":"65","author":"Yoshida","year":"2018","journal-title":"Endocr J"},{"issue":"2","key":"2019100118015788500_bib27","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.maturitas.2013.07.010","article-title":"The correlation between self-reported and measured height, weight, and BMI in reproductive age women","volume":"76","author":"Roth","year":"2013","journal-title":"Maturitas"},{"issue":"2","key":"2019100118015788500_bib28","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10995-006-0157-0","article-title":"Validity of self-reported height and weight in women of reproductive age","volume":"11","author":"Brunner Huber","year":"2007","journal-title":"Matern Child Health J"},{"issue":"4","key":"2019100118015788500_bib29","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s10995-008-0384-7","article-title":"Accuracy of body mass index categories based on self-reported height and weight among women in the United States","volume":"13","author":"Craig","year":"2009","journal-title":"Matern Child Health J"},{"issue":"3","key":"2019100118015788500_bib30","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.fertnstert.2018.05.004","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"110","author":"Teede","year":"2018","journal-title":"Fertil Steril"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/jc.2019-01357\/29104951\/jc.2019-01357.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/104\/11\/5382\/30094221\/jc.2019-01357.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,16]],"date-time":"2021-01-16T06:14:16Z","timestamp":1610777656000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/104\/11\/5382\/5544500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,7]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2019-01357","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,11]]},"published":{"date-parts":[[2019,8,7]]}}}